Therapeutic Antibodies

Pipeline

Kyowa Hakko Kirin is vigorously promoting research and development of therapeutic antibodies. By actively using our proprietary fully human antibody production technology, antibody-enhancing technology (POTELLIGENT®), and so on, we collaborate with partners around the globe to overcome challenges in the research and development of new therapeutic antibodies.

Kyowa Hakko Kirin's Antibody Pipeline Site